334 related articles for article (PubMed ID: 31773442)
1. The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options.
Chandran M; Lau TC; Gagnon-Arpin I; Dobrescu A; Li W; Leung MYM; Patil N; Zhao Z
Arch Osteoporos; 2019 Nov; 14(1):114. PubMed ID: 31773442
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and economic burden of osteoporosis in Switzerland.
Svedbom A; Ivergård M; Hernlund E; Rizzoli R; Kanis JA
Arch Osteoporos; 2014; 9():187. PubMed ID: 24970672
[TBL] [Abstract][Full Text] [Related]
3. Age- and gender-specific epidemiology, treatment patterns, and economic burden of osteoporosis and associated fracture in Taiwan between 2009 and 2013.
Wang CY; Fu SH; Yang RS; Shen LJ; Wu FL; Hsiao FY
Arch Osteoporos; 2017 Oct; 12(1):92. PubMed ID: 29067572
[TBL] [Abstract][Full Text] [Related]
4. Current and future economic burden of osteoporosis in New Zealand.
Brown P; McNeill R; Leung W; Radwan E; Willingale J
Appl Health Econ Health Policy; 2011 Mar; 9(2):111-23. PubMed ID: 21271750
[TBL] [Abstract][Full Text] [Related]
5. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
Hernlund E; Svedbom A; Ivergård M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jönsson B; Kanis JA
Arch Osteoporos; 2013; 8(1):136. PubMed ID: 24113837
[TBL] [Abstract][Full Text] [Related]
6. Projection of osteoporosis-related fractures and costs in China: 2010-2050.
Si L; Winzenberg TM; Jiang Q; Chen M; Palmer AJ
Osteoporos Int; 2015 Jul; 26(7):1929-37. PubMed ID: 25761729
[TBL] [Abstract][Full Text] [Related]
7. Osteoporosis in the European Union: a compendium of country-specific reports.
Svedbom A; Hernlund E; Ivergård M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jönsson B; Kanis JA;
Arch Osteoporos; 2013; 8(1):137. PubMed ID: 24113838
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
Majumdar SR; Lier DA; Hanley DA; Juby AG; Beaupre LA;
Osteoporos Int; 2017 Jun; 28(6):1965-1977. PubMed ID: 28275838
[TBL] [Abstract][Full Text] [Related]
9. Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs--an analysis using national health databases.
Olsen KR; Hansen C; Abrahamsen B
Osteoporos Int; 2013 Oct; 24(10):2639-47. PubMed ID: 23604250
[TBL] [Abstract][Full Text] [Related]
10. Reassessment of osteoporosis-related femoral fractures and economic burden in Saudi Arabia.
Sadat-Ali M; Al-Dakheel DA; Azam MQ; Al-Bluwi MT; Al-Farhan MF; AlAmer HA; Al-Meer Z; Al-Mohimeed A; Tabash IK; Karry MO; Rassasy YM; Baragaba MA; Amer AS; AlJawder A; Al-Bouri KM; ElTinay M; Badawi HA; Al-Othman AA; Tayara BK; Al-Faraidy MH; Amin AH
Arch Osteoporos; 2015; 10():37. PubMed ID: 26494131
[TBL] [Abstract][Full Text] [Related]
11. Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among women in China: a simulation projection model from 2020 to 2040.
Cui L; Jackson M; Wessler Z; Gitlin M; Xia W
Arch Osteoporos; 2021 Aug; 16(1):118. PubMed ID: 34338927
[TBL] [Abstract][Full Text] [Related]
12. Evaluation on the cost-effective threshold of osteoporosis treatment on elderly women in China using discrete event simulation model.
Ni W; Jiang Y
Osteoporos Int; 2017 Feb; 28(2):529-538. PubMed ID: 27581955
[TBL] [Abstract][Full Text] [Related]
13. Effect of improved medication adherence on health care costs in osteoporosis patients.
Cho H; Byun JH; Song I; Kim HY; Ha YC; Kim TY; Lee YK; Jang S
Medicine (Baltimore); 2018 Jul; 97(30):e11470. PubMed ID: 30045269
[TBL] [Abstract][Full Text] [Related]
14. Cost and management of males with closed fractures.
Brenneman SK; Yurgin N; Fan Y
Osteoporos Int; 2013 Mar; 24(3):825-33. PubMed ID: 22776864
[TBL] [Abstract][Full Text] [Related]
15. Cost-effective osteoporosis treatment thresholds in Greece.
Makras P; Athanasakis K; Boubouchairopoulou N; Rizou S; Anastasilakis AD; Kyriopoulos J; Lyritis GP
Osteoporos Int; 2015 Jul; 26(7):1949-57. PubMed ID: 25740208
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of pharmacological fracture prevention for osteoporosis as prescribed in clinical practice in France, Germany, Italy, Spain, and the United Kingdom.
Svedbom A; Hadji P; Hernlund E; Thoren R; McCloskey E; Stad R; Stollenwerk B
Osteoporos Int; 2019 Sep; 30(9):1745-1754. PubMed ID: 31270592
[TBL] [Abstract][Full Text] [Related]
17. A health economic simulation model for the clinical management of osteoporosis.
Jonsson E; Hansson-Hedblom A; Ljunggren Ö; Åkesson K; Spångeus A; Kanis JA; Borgström F
Osteoporos Int; 2018 Mar; 29(3):545-555. PubMed ID: 29196775
[TBL] [Abstract][Full Text] [Related]
18. Costs of osteoporosis related fractures in hospital admitted patients, Tigrai, Northern Ethiopia: a retrospective study.
Bayray A; Enquselassie F; Gebreegziabher Z
Ethiop Med J; 2013 Jul; 51(3):177-86. PubMed ID: 24669674
[TBL] [Abstract][Full Text] [Related]
19. Medical costs of osteoporosis in the elderly Medicare population.
Blume SW; Curtis JR
Osteoporos Int; 2011 Jun; 22(6):1835-44. PubMed ID: 21165602
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of missed opportunities for secondary fracture prevention in a regional general hospital setting in Singapore.
Gani L; Reddy SK; Alsuwaigh R; Khoo J; King TFJ
Arch Osteoporos; 2017 Dec; 12(1):60. PubMed ID: 28656564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
